Archive by Author

Satori Pharma doesn’t forget to raise $7M for Alzeimers

Posted on 21. Jan, 2011 by .

0

Satori Pharmaceuticals adds $7M for Alzeimers

Continue Reading

Genzyme: “Must keep Boston R&D intact”

Posted on 20. Jan, 2011 by .

0

According to a recent Boston Globe article, Genzyme CEO Henri Termeer stated: “That any purchaser Genyzme would want to keep its Boston area research and manufacturing operations intact, noting that the company’s science and its people are a key source of biotechnology innovation.  “Only then will they get the return on their investment,” he said.” [...]

Continue Reading